Arrowhead Research reported $146.54M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Anika Therapeutics ANIK:US $ 28.77M 12.6M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Cerulean Pharma CERU:US $ 15.91M 9.9M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Ligand Pharmaceuticals LGND:US $ 36.3M 16.2M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Moderna Inc MRNA:US 9.96B 1.12B
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Novartis NOVN:VX SF 29880M 247M
Opko Health OPK:US $ 283.04M 20.94M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Spectrum Pharmaceuticals SPPI:US $ 57.27M 0.57M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Xencor XNCR:US $ 44.32M 1.64M
YTE INCY:US $ 742.71M 82.39M